The vasoconstrictor effect of 8-epi prostaglandin F2alpha in the hypoxic rat heart
- PMID: 10205005
- PMCID: PMC1565897
- DOI: 10.1038/sj.bjp.0702433
The vasoconstrictor effect of 8-epi prostaglandin F2alpha in the hypoxic rat heart
Abstract
1. 8-epi prostaglandin (PG) F2alpha, a vasoconstrictor isoprostane, is synthesized under conditions of oxidative stress. This study was undertaken to investigate the vasoconstrictor effect of 8-epi PGF2alpha in the coronary circulation before and after a period of oxidative stress. 2. The effects of the isoprostane 8-epi PGF2alpha and the thromboxane mimetic U46619 were compared in the isolated rat heart perfused in the Langendorff mode at a constant pressure of 80 mmHg. 3. In normal hearts U46619 caused a dose-related reduction in coronary flow (ED50 4.7+/-2.2 nmol). In contrast, 8-epi PGF2alpha had no effect. 4. After reducing perfusion pressure to 20 mmHg for 30 min and reperfusing at 80 mmHg, the dose-response curve to U46619 was unaffected. In contrast, 8-epi PGF2alpha caused a dose-dependent drop in coronary flow (ED50 52.6+/-12.7 nmol), producing a similar maximal reduction to U46619. 5. Similarly, after perfusion with xanthine and xanthine oxidase for either 15 or 30 min there was little change in the response to U46619 in comparison to control hearts. In contrast, 8-epi PGF2alpha caused a reduction in coronary flow similar to that produced by U46619, the magnitude of the response being related to the length of xanthine/xanthine oxidase perfusion. 6. Responses to both U46619 and 8-epi PGF2alpha after xanthine/xanthine oxidase perfusion were blocked by the selective thromboxane receptor antagonist SQ29548 10(-7) M. 7. These results show that oxidative stress in the isolated perfused rat heart reveals a potent vasoconstrictor effect of the isoprostane 8-epi PGF2alpha by an action on the thromboxane receptor. 8. The data also suggest that, since 8-epi PGF2alpha is a partial agonist at the thromboxane receptor, thromboxane receptor reserve is increased by oxidative stress.
Figures


Similar articles
-
Actions of 8 epi prostaglandin F2alpha on isolated rat aorta.J Cardiovasc Pharmacol. 1998 Sep;32(3):471-8. doi: 10.1097/00005344-199809000-00019. J Cardiovasc Pharmacol. 1998. PMID: 9733362
-
Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha.Br J Pharmacol. 1996 Nov;119(6):1276-80. doi: 10.1111/j.1476-5381.1996.tb16033.x. Br J Pharmacol. 1996. PMID: 8937734 Free PMC article.
-
Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veins.J Cardiovasc Pharmacol. 2000 May;35(5):729-34. doi: 10.1097/00005344-200005000-00008. J Cardiovasc Pharmacol. 2000. PMID: 10813374
-
Vasoactive effects of 8-epi-prostaglandin F(2alpha)in isolated human placental conduit and resistance blood vessels in vitro.Placenta. 2001 Jul;22(6):526-33. doi: 10.1053/plac.2001.0690. Placenta. 2001. PMID: 11440540
-
Bronchoconstrictive properties of inhaled 8-epi-PGF2alpha in healthy and heaves-susceptible horses.Vet Res. 2001 Sep-Oct;32(5):397-407. doi: 10.1051/vetres:2001132. Vet Res. 2001. PMID: 11592610
Cited by
-
Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species.J Lipid Res. 2009 Jun;50(6):1047-56. doi: 10.1194/jlr.M800447-JLR200. Epub 2009 Jan 16. J Lipid Res. 2009. PMID: 19151335 Free PMC article.
-
Regulation of thromboxane receptor signaling at multiple levels by oxidative stress-induced stabilization, relocation and enhanced responsiveness.PLoS One. 2010 Sep 15;5(9):e12798. doi: 10.1371/journal.pone.0012798. PLoS One. 2010. PMID: 20856817 Free PMC article.
-
Effects of some isoprostanes on the human umbilical artery in vitro.Br J Pharmacol. 2000 Feb;129(3):509-14. doi: 10.1038/sj.bjp.0703083. Br J Pharmacol. 2000. PMID: 10711349 Free PMC article.
-
Neutrophils mediate early cerebral cortical hypoperfusion in a murine model of subarachnoid haemorrhage.Sci Rep. 2019 Jun 11;9(1):8460. doi: 10.1038/s41598-019-44906-9. Sci Rep. 2019. PMID: 31186479 Free PMC article.
-
15-F-isoprostane and 5-F-isoprostane are not triggers of myocardial preconditioning.Clin Exp Pharmacol Physiol. 2005 May-Jun;32(5-6):350-4. doi: 10.1111/j.1440-1681.2005.04195.x. Clin Exp Pharmacol Physiol. 2005. PMID: 15854141 Free PMC article.
References
-
- BANERJEE M., KANG K.H., MORROW J.D., ROBERTS L.J., NEWMAN J.H. Effects of a novel prostaglandin, 8-epi PGF2α, in rabbit lung in situ. Am. J. Physiol. 1992;263:H660–H663. - PubMed
-
- BASU D.K., KARMAZYN M. Injury to rat hearts produced by an exogenous free radical generating system. Study into the role of arachidonic acid and eiconsanoids. J. Pharmacol. Exp. Ther. 1987;242:673–685. - PubMed
-
- CRANKSHAW D. Effects of the isoprostane, 8-epi prostaglandin F2α, on the contractility of the human myometrium in vitro. Eur. J. Pharmacol. 1995;285:151–158. - PubMed
-
- CURTIS M.J., MACLEOD B.A., TABRIZCHI R., WALKER M.J. An improved perfusion apparatus for small animal hearts. J. Pharm. Methods. 1986;15:87–94. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources